Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct : a secondary analysis of the SELECT2 randomized trial
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ..
BACKGROUND: The incidence of intracerebral hemorrhage (ICH) and its effect on the outcomes after endovascular thrombectomy (EVT) for patients with large core infarcts have not been well-characterized.
METHODS: SELECT2 trial follow-up imaging was evaluated using the Heidelberg Bleeding Classification (HBC) to define hemorrhage grade. The association of ICH with clinical outcomes and treatment effect was examined.
RESULTS: Of 351 included patients, 194 (55%) and 189 (54%) demonstrated intracranial and intracerebral hemorrhage, respectively, with a higher incidence in EVT (134 (75%) and 130 (73%)) versus medical management (MM) (60 (35%) and 59 (34%), both P<0.001). Hemorrhagic infarction type 1 (HBC=1a) and type 2 (HBC=1b) accounted for 93% of all hemorrhages. Parenchymal hematoma (PH) type 1 (HBC=1c) and type 2 (HBC=2) were observed in 1 (0.6%) EVT-treated and 4 (2.2%) MM patients. Symptomatic ICH (sICH) (SITS-MOST definition) was seen in 0.6% EVT patients and 1.2% MM patients. No trend for ICH with core volumes (P=0.10) or Alberta Stroke Program Early CT Score (ASPECTS) (P=0.74) was observed. Among EVT patients, the presence of any ICH did not worsen clinical outcome (modified Rankin Scale (mRS) at 90 days: 4 (3-6) vs 4 (3-6); adjusted generalized OR 1.00, 95% CI 0.68 to 1.47, P>0.99) or modify EVT treatment effect (Pinteraction=0.77).
CONCLUSIONS: ICH was present in 75% of the EVT population, but PH or sICH were infrequent. The presence of any ICH did not worsen functional outcomes or modify EVT treatment effect at 90-day follow-up. The high rate of hemorrhages overall still represents an opportunity for adjunctive therapies in EVT patients with a large ischemic core.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of neurointerventional surgery - (2024) vom: 12. März |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
Complication |
---|
Anmerkungen: |
Date Revised 12.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1136/jnis-2023-021219 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369614828 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369614828 | ||
003 | DE-627 | ||
005 | 20240313235146.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/jnis-2023-021219 |2 doi | |
028 | 5 | 2 | |a pubmed24n1326.xml |
035 | |a (DE-627)NLM369614828 | ||
035 | |a (NLM)38471760 | ||
035 | |a (PII)jnis-2023-021219 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Michael |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct |b a secondary analysis of the SELECT2 randomized trial |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a BACKGROUND: The incidence of intracerebral hemorrhage (ICH) and its effect on the outcomes after endovascular thrombectomy (EVT) for patients with large core infarcts have not been well-characterized | ||
520 | |a METHODS: SELECT2 trial follow-up imaging was evaluated using the Heidelberg Bleeding Classification (HBC) to define hemorrhage grade. The association of ICH with clinical outcomes and treatment effect was examined | ||
520 | |a RESULTS: Of 351 included patients, 194 (55%) and 189 (54%) demonstrated intracranial and intracerebral hemorrhage, respectively, with a higher incidence in EVT (134 (75%) and 130 (73%)) versus medical management (MM) (60 (35%) and 59 (34%), both P<0.001). Hemorrhagic infarction type 1 (HBC=1a) and type 2 (HBC=1b) accounted for 93% of all hemorrhages. Parenchymal hematoma (PH) type 1 (HBC=1c) and type 2 (HBC=2) were observed in 1 (0.6%) EVT-treated and 4 (2.2%) MM patients. Symptomatic ICH (sICH) (SITS-MOST definition) was seen in 0.6% EVT patients and 1.2% MM patients. No trend for ICH with core volumes (P=0.10) or Alberta Stroke Program Early CT Score (ASPECTS) (P=0.74) was observed. Among EVT patients, the presence of any ICH did not worsen clinical outcome (modified Rankin Scale (mRS) at 90 days: 4 (3-6) vs 4 (3-6); adjusted generalized OR 1.00, 95% CI 0.68 to 1.47, P>0.99) or modify EVT treatment effect (Pinteraction=0.77) | ||
520 | |a CONCLUSIONS: ICH was present in 75% of the EVT population, but PH or sICH were infrequent. The presence of any ICH did not worsen functional outcomes or modify EVT treatment effect at 90-day follow-up. The high rate of hemorrhages overall still represents an opportunity for adjunctive therapies in EVT patients with a large ischemic core | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Complication | |
650 | 4 | |a Hemorrhage | |
650 | 4 | |a Stroke | |
650 | 4 | |a Thrombectomy | |
650 | 4 | |a Thrombolysis | |
700 | 1 | |a Joshi, Krishna C |e verfasserin |4 aut | |
700 | 1 | |a Kolb, Bradley |e verfasserin |4 aut | |
700 | 1 | |a Sitton, Clark W |e verfasserin |4 aut | |
700 | 1 | |a Pujara, Deep Kiritbhai |e verfasserin |4 aut | |
700 | 1 | |a Abraham, Michael G |e verfasserin |4 aut | |
700 | 1 | |a Ortega-Gutierrez, Santiago |e verfasserin |4 aut | |
700 | 1 | |a Kasner, Scott E |e verfasserin |4 aut | |
700 | 1 | |a Hussain, Shazam M |e verfasserin |4 aut | |
700 | 1 | |a Churilov, Leonid |e verfasserin |4 aut | |
700 | 1 | |a Blackburn, Spiros |e verfasserin |4 aut | |
700 | 1 | |a Sundararajan, Sophia |e verfasserin |4 aut | |
700 | 1 | |a Hu, Yin C |e verfasserin |4 aut | |
700 | 1 | |a Herial, Nabeel |e verfasserin |4 aut | |
700 | 1 | |a Arenillas, Juan F |e verfasserin |4 aut | |
700 | 1 | |a Tsai, Jenny P |e verfasserin |4 aut | |
700 | 1 | |a Budzik, Ronald F |e verfasserin |4 aut | |
700 | 1 | |a Hicks, William |e verfasserin |4 aut | |
700 | 1 | |a Kozak, Osman |e verfasserin |4 aut | |
700 | 1 | |a Yan, Bernard |e verfasserin |4 aut | |
700 | 1 | |a Cordato, Dennis |e verfasserin |4 aut | |
700 | 1 | |a Manning, Nathan W |e verfasserin |4 aut | |
700 | 1 | |a Parsons, Mark |e verfasserin |4 aut | |
700 | 1 | |a Hanel, Ricardo A |e verfasserin |4 aut | |
700 | 1 | |a Aghaebrahim, Amin |e verfasserin |4 aut | |
700 | 1 | |a Wu, Teddy |e verfasserin |4 aut | |
700 | 1 | |a Cardona Portela, Pere |e verfasserin |4 aut | |
700 | 1 | |a Gandhi, Chirag D |e verfasserin |4 aut | |
700 | 1 | |a Al-Mufti, Fawaz |e verfasserin |4 aut | |
700 | 1 | |a Perez de la Ossa, Natalia |e verfasserin |4 aut | |
700 | 1 | |a Schaafsma, Joanna |e verfasserin |4 aut | |
700 | 1 | |a Blasco, Jordi |e verfasserin |4 aut | |
700 | 1 | |a Sangha, Navdeep |e verfasserin |4 aut | |
700 | 1 | |a Warach, Steven |e verfasserin |4 aut | |
700 | 1 | |a Kleinig, Timothy J |e verfasserin |4 aut | |
700 | 1 | |a Johns, Hannah |e verfasserin |4 aut | |
700 | 1 | |a Shaker, Faris |e verfasserin |4 aut | |
700 | 1 | |a Abdulrazzak, Mohammad A |e verfasserin |4 aut | |
700 | 1 | |a Ray, Abhishek |e verfasserin |4 aut | |
700 | 1 | |a Sunshine, Jeffery |e verfasserin |4 aut | |
700 | 1 | |a Opaskar, Amanda |e verfasserin |4 aut | |
700 | 1 | |a Duncan, Kelsey R |e verfasserin |4 aut | |
700 | 1 | |a Xiong, Wei |e verfasserin |4 aut | |
700 | 1 | |a Al-Shaibi, Faisal K |e verfasserin |4 aut | |
700 | 1 | |a Samaniego, Edgar A |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Thanh N |e verfasserin |4 aut | |
700 | 1 | |a Fifi, Johanna T |e verfasserin |4 aut | |
700 | 1 | |a Tjoumakaris, Stavropoula I |e verfasserin |4 aut | |
700 | 1 | |a Jabbour, Pascal |e verfasserin |4 aut | |
700 | 1 | |a Mendes Pereira, Vitor |e verfasserin |4 aut | |
700 | 1 | |a Lansberg, Maarten G |e verfasserin |4 aut | |
700 | 1 | |a Sila, Cathy |e verfasserin |4 aut | |
700 | 1 | |a Bambakidis, Nicholas C |e verfasserin |4 aut | |
700 | 1 | |a Davis, Stephen |e verfasserin |4 aut | |
700 | 1 | |a Wechsler, Lawrence |e verfasserin |4 aut | |
700 | 1 | |a Albers, Gregory W |e verfasserin |4 aut | |
700 | 1 | |a Grotta, James C |e verfasserin |4 aut | |
700 | 1 | |a Ribo, Marc |e verfasserin |4 aut | |
700 | 1 | |a Hassan, Ameer E |e verfasserin |4 aut | |
700 | 1 | |a Campbell, Bruce |e verfasserin |4 aut | |
700 | 1 | |a Hill, Michael D |e verfasserin |4 aut | |
700 | 1 | |a Sarraj, Amrou |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neurointerventional surgery |d 2009 |g (2024) vom: 12. März |w (DE-627)NLM19772521X |x 1759-8486 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:12 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/jnis-2023-021219 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 12 |c 03 |